Spyre Therapeutics SYRE
NASDAQ SYRE
$105.86 +1.38 (+1.32%)
As of: Nov 11, 2026 · 1:32 PM EST

Spyre Therapeutics (SYRE) Return on Equity [ROE] (2016 - 2026)

Updated

Spyre Therapeutics (SYRE) posted Return on Equity [ROE] of -24.51% for Q3 2026, up 8.19 percentage points from -32.71% a year earlier but down 4.32 percentage points from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2025, Spyre Therapeutics' Return on Equity [ROE] came in at -25.17%, up 34.11 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +55.75 percentage points (FY2020 to FY2025).
  • In prior years, Spyre Therapeutics' Return on Equity [ROE] was -59.28% in FY2024 (+229.89 pp), -289.17% in FY2023 (-164.30 pp), -124.87% in FY2022 (-66.06 pp) and -58.81% in FY2021 (+22.12 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -216.62% in Q1 2024 to a high of -20.19% in Q2 2026 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last seven quarters, with an average year-over-year change of +42.94 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 174.85 percentage points; the weakest was Q1 2023, with a drop of 86.41 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -20.19% (Q2 2026), -25.89% (Q1 2026) and -26.52% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Spyre Therapeutics 9.40 Bn 5.68 Bn - -24.51%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -24.51%
Jun 30, 2026 -20.19%
Mar 31, 2026 -25.89%
Dec 31, 2025 -26.52%
Sep 30, 2025 -32.71%
Jun 30, 2025 -44.08%
Mar 31, 2025 -41.77%
Dec 31, 2024 -49.22%
Sep 30, 2024 -61.25%
Jun 30, 2024 -70.63%
Mar 31, 2024 -216.62%
Mar 31, 2023 -185.34%
Dec 31, 2022 -142.23%
Sep 30, 2022 -112.63%
Jun 30, 2022 -120.03%
Mar 31, 2022 -98.93%
Dec 31, 2021 -70.71%
Sep 30, 2021 -61.54%
Jun 30, 2021 -54.18%
Mar 31, 2021 -60.97%
API Access

Spyre Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SYRE&period=max&api_key=YOUR_API_KEY